Management of severe and complicated malaria

Journal of Postgraduate Medicine

Volumn 52, Issue 4, 2006, Pages 281-287

  Mishra, S K ^a   Mohanty, S ^a   Mohanty, A ^a   Das, B S ^b  

^a ISPAT GENERAL HOSPITAL   (India)

^b NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

Author keywords

Cerebral; Malaria; Renal failure; Severe malaria

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ARTEETHER; ARTEMETHER; ARTEMISININ DERIVATIVE; ARTESUNATE; BICARBONATE; CORTICOSTEROID; DEFERIPRONE; DEFEROXAMINE; DEXAMETHASONE; DEXTRAN; DIAZEPAM; FUROSEMIDE; MANNITOL; MEFLOQUINE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OSMOTIC DIURETIC AGENT; PARACETAMOL; PARALDEHYDE; PENTOXIFYLLINE; PHENOBARBITAL; PHENYTOIN; QUINIDINE; QUININE; STEROID; UREA;

ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANAPHYLAXIS; ANEMIA; BLEEDING TENDENCY; BRAIN EDEMA; BRAIN MALARIA; CLINICAL TRIAL; CONFERENCE PAPER; CONVULSION; DISEASE SEVERITY; DRUG EFFICACY; DRUG FATALITY; DRUG INHIBITION; EARLY DIAGNOSIS; ELECTROLYTE DISTURBANCE; EXCHANGE BLOOD TRANSFUSION; FATALITY; FEVER; GASTROINTESTINAL HEMORRHAGE; GRAM NEGATIVE SEPSIS; HEART ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; HYPOTENSION; INDIA; INFECTION; JAUNDICE; KIDNEY FAILURE; LUNG COMPLICATION; LUNG EDEMA; MALARIA FALCIPARUM; METABOLIC ACIDOSIS; MORTALITY; MULTIPLE ORGAN FAILURE; PALLIATIVE THERAPY; PARASITEMIA; PLASMODIUM FALCIPARUM; PREGNANT WOMAN; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; SENSORY SYSTEM; SHOCK; UNCONSCIOUSNESS; UNSPECIFIED SIDE EFFECT;

ADULT; CHILD; HUMANS; MALARIA, FALCIPARUM; SEVERITY OF ILLNESS INDEX;

EID: 33845243110     PISSN: 00223859     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Snow RW, Guerra CA, Noor AM, Mvint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-7.
2. The World Health Organization (WHO). Guidelines for the treatment of malaria. 2006. p. 8-11. WHO/HTM/MAL/2006.1108
3. rd ed. Trans R Soc Trop Med Hyg 2000;94:1-90.
4. Mehta SR, Kohle VS, Chauhan SS. The changed clinical spectrum of malaria due to drug resistance. J Assoc Physics India 1998;46:360-2.
5. Prakash J, Gupta A, Kumar O, Rout SB, Malhotra V, Srivastava PK. Acute renal failure in falciparum malaria - Increasing prevalence in some areas of India - A need for awareness. Nephrol Dial Transplant 1996;11:2414-6.
6. Mehta KS, Halankar AR, Makwana PD, Torane PP, Satija PS, Shah VB. Severe acute renal failure in malaria. J Postgrad Med 2001;47:24-6.
7. Mohanty S, Mishra SK, Satpathy SK, Mohanty D, Mohapatra DN. Comparison of intramuscular arteether versus quinine in the treatment of cerebral malaria. J Indian Acad Clin Med 2000;5:119-23.
8. Faiz MA, Rahman E, Hossain MA, Rahman MR, Yunus EB, Samad R, et al. A randomized controlled trial comparing artemether and quinine in the treatment of severe falciparum malaria in Bangladesh. Indian J Malariol 2001;38:9-18.
9. Newton PN, Angus BJ, Chierakul W, Dondorp A, Ruangveerayuth R, Silamut K, et al. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria. Clin Infect Dis 2003;37:7-16.
10. Dondorp A, Nosten F, Stepniewska K, Day N, White N; South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. Artesunate versus quinine for treatment of severe falciparum malaria: A randomized trial. Lancet 2005;366:717-25.
11. Satpathy R, Das DB, Nanda NC, Patnaik JK, Mishra SK, Das BS. Complication of intramuscular quinine injection: Three case reports. Indian J Malariol 1993;30:45-9.
12. Brandts CH, Ndjare M, Graninger W, Kremsener, PG. Effect of paracetamol on parasite clearance time in P falciparum malaria. Lancet 1997;350:704-9.
13. White NJ, Looareesuwan S, Phillips RE, Chanthavanich P, Warrell DA. Single dose of Phenobarbitone prevents convulsions in cerebral malaria. Lancet 1988;2:64-6.
14. Das BS, Satpathy SK, Mohanty D, Mohanty S, Mishra SK, Satapathy PC, et al. Hypoglycaemia in severe falciparum malaria. Trans R Soc Trop Med Hyg 1988;82:197-201.
15. Mishra SK, Mohanty S, Das BS, Patnaik JK, Satpathy SK, Mohanty D, et al. Hepatic changes in P. falciparum malaria. Indian J Malariol 1992;29:167-71.
16. Mishra SK, Pati SS, Satpathy SK, Mohanty S, Mohapatra DN. The influence of hyperbilirubinaemia on malaria-related mortality: An analysis of 1103 patients. Ann Trop Med Parasitol 2004;98:555-8.
17. Warrell DA, Looareesuwan S, Warrell MJ, Kasemsarn P, Intraprasert R, Bunnag D, et al. Dexamethasone proves deleterious in cerebral malaria. A double blind trial in 100 comatose patients. N Engl J Med 1982;306:313-9.
18. Hoffmann SL, Rustama D, Punjabi NH, Surampaet B, Sanjaya B, Dimpudus AJ, et al. High-dose dexamethasone in quinine-treated patients with cerebral malaria: A double blind, placebo-controlled trial. J Infect Dis 1988;158:325-31.
19. Newton CR, Kirkham FJ, Winstanley PA, Pasvol G, Peshu N, Warrell DA, et al. Intracranial pressure in African children with cerebral malaria. Lancet 1991;337:573-6.
20. Warrell DA. Management of severe malaria. Parasitologia 1999;41:287-94.
21. Flemming AF, Allen NC. Severe hemolytic anaemia in pregnancy in Nigerians treated with prednisolone. Br Med J 1969;4:461-6.
22. rd. Early steroid therapy for respiratory failure. Arch Surg 1985;120:536-40.
23. Bone RC, Fissher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled trial of Methyl prednisolone in the treatment of severe sepsis and septic shock. N Eng J Med 1987;317:653-8.
24. WHO. The Clinical Management of Acute Malaria. World Health Organization Regional office For South-East Asia: New Delhi; 1980.
25. Ng RC, Suki WN. Treatment of acute renal failure In: Brenner BM, Stein JH (editors.) Acute renal failure. Churchill Livingstone: New York; 1980. p. 229-73.
26. Looareesuwan S, Warrell DA, White NJ, Suntharasamai P, Chanthavanich P, Sundaravej K, et al. Do patients with cerebral malaria have cerebral oedema? A computer tomographic study. Lancet 1983;1:434-7.
27. Greninger W, Thalhammer F, Locker G. Pentoxyfylline in cerebral malaria. J Infect Dis 1991;164:829.
28. Landau Z, Attali M. Use of pentoxyfylline in the treatment of cerebral malaria. Clin Infect Dis 1993;17:137.
29. Di Perri G, Di Perri IG, Monterio GB, Bonora S, Hennig C, Cassatella M, et al. Pentoxyfylline as a supportive agent in treatment of cerebral malaria in children, J Infect Dis 1995;171:1317-22.
30. Looareesuwan S, Wilairatana P, Vannaphan S, Wanaratana V, Wenisch C, Aikawa M, et al. Pentoxyfylline as an ancillary treatment for severe falciparum malaria in Thailand. Am J Trop Med Hyg 1998;58:348-53.
31. Das BK, Mishra S, Padhi PK, Manish R, Tripathy R, Sahoo PK, et al. Pentoxifylline adjunct improves prognosis of human cerebral malaria in adults. Trop Med Int Health 2003;8:680-4.
32. Lewis DH. Dextran 30 years. Almquist and Wiksell: Uppsala; 1977.
33. Gordeuk VR, Thuma PE, Brittenham GN. Iron chelation therapy for malaria. Adv Exp Med Bio 1994;356:371-83.
34. Thuma PE, Mabeza GF, Biemba G, Bhat GJ, McLaren CE, Moyo VM, et al. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hyg 1998;92:214-8.
35. Mohanty D, Ghosh K, Pathare AV, Karnad D. Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. Indian J Med Res 2002;115:17-21.
36. Field JW, Niven JC. A note on prognosis in relation to parasitic counts in acute sub-tertian malaria. Trans Royal Trop Med Hyg 1937;30:569-74.
37. Wilkinson RJ, Brown JL, Pasvol G, Chiodini PL, Davidson RN. Severe falciparum malaria: Predicting the effect of exchange transfusion. Quart J Med 1994;87:553-7.
38. Mohanty S, Mishra SK, Pati SS, Pattnaik JK, Das BS. Complications and mortality patterns due to Plasmodium falciparum malaria in hospitalized adults and children, Rourkela, Orissa, India. Trans R Soc Trop Med Hyg 2003;97:69-70.